EMA: World AIDS Day 2013 – Revised guidance to facilitate development of new medicines

The document provides a new definition of populations included in clinical trials, moving away from a focus on treatment history (distinguishing between treatment-naïve and treatment-experienced patients) to an emphasis on documented viral resistance. Guidance is provided on the development programmes and the type of data that should be provided for new antiretroviral agents.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny